(c) 2024 PillSync.com

atorvastatin calcium 20 mg

1 INDICATIONS AND USAGE Atorvastatin calcium tablets are indicated: To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD As an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH). As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia Hypertriglyceridemia Atorvastatin calcium tablet is an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): To reduce the risk of: Myocardial infarction (MI), stroke, revascularization procedures, and angina in adults with multiple risk factors for coronary heart disease (CHD) but without clinically evident CHD. MI and stroke in adults with type 2 diabetes mellitus with multiple risk factors for CHD but without clinically evident CHD. Non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure, and angina in adults with clinically evident CHD. As an adjunct to diet to reduce low-density lipoprotein (LDL-C) in: Adults with primary hyperlipidemia. Adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). As an adjunct to other LDL-C-lowering therapies to reduce LDL-C in adults and pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia. As an adjunct to diet for the treatment of adults with: Primary dysbetalipoproteinemia. Hypertriglyceridemia

dr. reddy's laboratories inc


1 year ago OVAL WHITE C2 atorvastatin calcium 20 mg

OVAL WHITE C2

1 year ago OVAL WHITE C2 atorvastatin calcium 20 mg

C2 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

ATORVASTATIN CALCIUM tablets USP, 10 mg are white to off-white oval shaped, film-coated tablets with ‘C1’ on one side and plain on other side and free from physical defects. Bottles of 90 NDC 43598-830-90 Bottles of 500 NDC 43598-830-05 Unit-dose blister package of 100 (10x10) NDC 43598-830-78

ATORVASTATIN CALCIUM tablets USP, 20 mg are white to off-white oval shaped, film-coated tablets with ‘C2’ on one side and plain on other side and free from physical defects. Bottles of 90 NDC 43598-831-90 Bottles of 500 NDC 43598-831-05 Unit-dose blister package of 100 (10x10) NDC 43598-831-78

ATORVASTATIN CALCIUM tablets USP, 40 mg are white to off-white oval shaped, film-coated tablets with ‘C3’ on one side and plain on other side and free from physical defects. Bottles of 90 NDC 43598-832-90 Bottles of 500 NDC 43598-832-05 Unit-dose blister package of 100 (10x10)NDC 43598-832-78

ATORVASTATIN CALCIUM tablets USP, 80 mg are white to off-white oval shaped, film-coated tablets with ‘C4’ on one side and plain on other side and free from physical defects. Bottles of 90 NDC 43598-833-90 Bottles of 500 NDC 43598-833-05 Unit-dose blister package of 30 (3x10) NDC 43598-833-81 Storage Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].


More pills like OVAL C2

Related Pills

atorvastatin calcium 10 mg

Dr. Reddy\'s Laboratories Inc

atorvastatin calcium 20 mg

Dr. Reddy\'s Laboratories Inc

atorvastatin calcium 40 mg

Dr. Reddy\'s Laboratories Inc

cimetidine 200 mg

aurobindo pharma limited

pantoprazole 40 MG Delayed Release Oral Tablet

Jubilant Cadista Pharmaceuticals Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site